Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Emblem Corp EMMBF

"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."

OTCPK:EMMBF - Post Discussion

Emblem Corp > Whassup with Emblem and these guys?
View:
Post by indaknownewfie on Jan 11, 2018 10:01pm

Whassup with Emblem and these guys?

Yesterday Queensland Bauxite (mining company) on the Australian exchange makes a deal with a Canadian company Canntabs Therapeutics to sell controlled dose cannabis capsules. In November Canadian mining company Telferscot Resources signed a Letter of Intent (LOI) to purchase all oustanding shares of Canntabs Therapeutics which was a private company to take it public on the stock exchange CSE This deal closes next month. In the mix is Emblem Corp. 

Telferscot Resources is currently trading at 0.06 cents, anyone know where its heading and what Emblem's stake in the game is?
Comment by deminimis on Jan 11, 2018 11:20pm
Emblem has no stake in this company although I suspect they might buy into the $5M bought deal Canntab is doing concurrently with the reverse takeover.  Emblem’s involvement with this company is that they have licensed Canntab’s Canadian patent on a cannabis sustained release formulation and have entered into a partnership with them to develop other pharmaceutical formulations. I haven’t ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities